(Total Views: 594)
Posted On: 12/29/2020 11:09:47 AM
Post# of 148905
Enjay,
I have been back and forth a bit with one of the WaPost sciences writers who has covered Covid pathology and therapeutics. No luck so far, but sent an update last night in a similar vein to that posted by Ross.
My belief is that major media and investors are all waiting on CD12 results. Appropriate though frustrating.
Open label extension and resumption of eINDs is likely the best we will see until results.
Two weeks is an additional 30+K deaths but who's counting?
I have been back and forth a bit with one of the WaPost sciences writers who has covered Covid pathology and therapeutics. No luck so far, but sent an update last night in a similar vein to that posted by Ross.
My belief is that major media and investors are all waiting on CD12 results. Appropriate though frustrating.
Open label extension and resumption of eINDs is likely the best we will see until results.
Two weeks is an additional 30+K deaths but who's counting?
(7)
(0)Scroll down for more posts ▼
